Skip to main content
CATALYST PHARMACEUTICALS, INC. logo

CATALYST PHARMACEUTICALS, INC. — Investor Relations & Filings

Ticker · CPRX ISIN · US14888U1016 LEI · 5299004O0R5XXLA5H544 US Manufacturing
Filings indexed 1,129 across all filing types
Latest filing 2025-11-25 Director's Dealing
Country US United States of America
Listing US CPRX

About CATALYST PHARMACEUTICALS, INC.

https://catalystpharma.com/

Catalyst Pharmaceuticals, Inc. is a commercial-stage biopharmaceutical company focused on in-licensing, developing, and commercializing prescription drugs for rare diseases. The company is dedicated to improving the lives of patients with underserved medical conditions, particularly in the fields of neurology and epilepsy. Its portfolio includes therapies for rare autoimmune disorders such as Lambert-Eaton myasthenic syndrome (LEMS). The company also markets FYCOMPA (perampanel), a medication used to treat partial-onset seizures.

Recent filings

Filing Released Lang Actions
FORM 4 FOR 11-20-2025
Director's Dealing
2025-11-25 English
FORM 4 FOR 11-12-2025
Director's Dealing
2025-11-14 English
Regulatory Filings 2025
Regulatory Filings
2025-11-12 English
8-K
Regulatory Filings
2025-11-05 English
10-Q
Interim / Quarterly Report 9M 2025
2025-11-05 English
8-K
Regulatory Filings
2025-10-01 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.